1. Home
  2. PPBT vs MOVE Comparison

PPBT vs MOVE Comparison

Compare PPBT & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • MOVE
  • Stock Information
  • Founded
  • PPBT 2010
  • MOVE 2018
  • Country
  • PPBT Israel
  • MOVE United States
  • Employees
  • PPBT N/A
  • MOVE N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PPBT Health Care
  • MOVE Health Care
  • Exchange
  • PPBT Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • PPBT 6.3M
  • MOVE 5.3M
  • IPO Year
  • PPBT N/A
  • MOVE 2021
  • Fundamental
  • Price
  • PPBT $2.34
  • MOVE $0.70
  • Analyst Decision
  • PPBT Strong Buy
  • MOVE Buy
  • Analyst Count
  • PPBT 1
  • MOVE 1
  • Target Price
  • PPBT $33.00
  • MOVE $30.00
  • AVG Volume (30 Days)
  • PPBT 29.4K
  • MOVE 250.0K
  • Earning Date
  • PPBT 08-15-2025
  • MOVE 08-13-2025
  • Dividend Yield
  • PPBT N/A
  • MOVE N/A
  • EPS Growth
  • PPBT N/A
  • MOVE N/A
  • EPS
  • PPBT N/A
  • MOVE N/A
  • Revenue
  • PPBT N/A
  • MOVE $1,013,000.00
  • Revenue This Year
  • PPBT N/A
  • MOVE $1,460.71
  • Revenue Next Year
  • PPBT N/A
  • MOVE $96.77
  • P/E Ratio
  • PPBT N/A
  • MOVE N/A
  • Revenue Growth
  • PPBT N/A
  • MOVE N/A
  • 52 Week Low
  • PPBT $2.00
  • MOVE $0.51
  • 52 Week High
  • PPBT $13.95
  • MOVE $6.97
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 41.27
  • MOVE 47.73
  • Support Level
  • PPBT $2.30
  • MOVE $0.61
  • Resistance Level
  • PPBT $2.45
  • MOVE $0.85
  • Average True Range (ATR)
  • PPBT 0.14
  • MOVE 0.10
  • MACD
  • PPBT -0.03
  • MOVE 0.02
  • Stochastic Oscillator
  • PPBT 16.58
  • MOVE 43.49

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: